![Robert Peach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Peach
Director/Board Member at
AMPLIA THERAPEUTICS LIMITED
Net worth: 466 050 $ as of 31/05/2026
Profile
Robert J.
Peach was the founder of Apoptos, Inc. (2007) as Vice President-Biology and Receptos LLC (2009) as Chief Scientific Officer.
Dr. Peach is currently an Independent Non-Executive Director at Amplia Therapeutics Ltd. since 2015.
Former positions include Senior Director-Oncology Discovery at Biogen, Inc. (2005-2007), Director at Avalia Immunotherapies Ltd., Independent Non-Executive Director at AdAlta Ltd. (2016-2024), and Principal at Bristol Myers Squibb Co. (1991-2000).
Education includes a doctorate from the University of Otago and undergraduate and graduate degrees from the University of Canterbury.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/09/2025 | 47,98,212 ( 0.93% ) | 466 050 $ | 31/05/2026 |
Robert Peach active positions
| Companies | Position | Start |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Director/Board Member | 02/09/2015 |
Former positions of Robert Peach
| Companies | Position | End |
|---|---|---|
| ADALTA LIMITED | Director/Board Member | 20/11/2024 |
| RECEPTOS INC | Founder | 27/08/2015 |
Apoptos, Inc.
 Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule anticancer drugs | Founder | 01/05/2009 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Robert Peach
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Apoptos, Inc.
Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule anticancer drugs | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Canterbury
 University of Canterbury Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdAlta Ltd.
 AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Amplia Therapeutics Ltd.
 Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis | Health Technology |
Avalia Immunotherapies Ltd.
 Avalia Immunotherapies Ltd. Medical/Nursing ServicesHealth Services Engages in developing immunotherapy’s that support the treatment of cancer and other diseases | Health Services |
- Stock Market
- Insiders
- Robert Peach
